Does LEFLUNOMIDE Cause Hepatic steatosis? 359 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 359 reports of Hepatic steatosis have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.6% of all adverse event reports for LEFLUNOMIDE.
359
Reports of Hepatic steatosis with LEFLUNOMIDE
0.6%
of all LEFLUNOMIDE reports
0
Deaths
68
Hospitalizations
How Dangerous Is Hepatic steatosis From LEFLUNOMIDE?
Of the 359 reports, 68 (18.9%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Hepatic steatosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 359 reports have been filed with the FAERS database.
What Other Side Effects Does LEFLUNOMIDE Cause?
Drug ineffective (31,396)
Rheumatoid arthritis (20,886)
Pain (15,594)
Drug intolerance (14,142)
Joint swelling (13,026)
Fatigue (11,959)
Arthralgia (11,880)
Rash (11,239)
Contraindicated product administered (11,206)
Abdominal discomfort (10,333)
What Other Drugs Cause Hepatic steatosis?
METHOTREXATE (1,400)
ADALIMUMAB (1,058)
ETANERCEPT (620)
TOCILIZUMAB (476)
TOFACITINIB (405)
HYDROXYCHLOROQUINE (358)
ABATACEPT (345)
METFORMIN (343)
INFLIXIMAB (325)
SECUKINUMAB (308)
Which LEFLUNOMIDE Alternatives Have Lower Hepatic steatosis Risk?
LEFLUNOMIDE vs LEMBOREXANT
LEFLUNOMIDE vs LENACAPAVIR
LEFLUNOMIDE vs LENALIDOMIDE
LEFLUNOMIDE vs LENIOLISIB
LEFLUNOMIDE vs LENOGRASTIM